The inhibition of CERK restricts AKT activation and translocation to mitochondria in mutant KRAS lung cancer, blocks phosphorylation of mitochondrial membrane potential related protein VDAC, thus affecting iron ptosis and cancer cell survival (63). The gene discussed is CERK; the disease is cancer.